Spectrophotometric and spectrofluorometric methods for the assay of lisinopril in single and multicomponent pharmaceutical dosage forms.
Simple and sensitive methods are described for the assay of lisinopril in tablets. The first method (A) is based on the reaction of the drug with chloranil in aqueous solution of pH 9.5 to give yellow colour measured at 346 nm. The second method (B) is based upon the interaction of lisinopril with dichlone resulting in the formation of an intense purple colour measured at 580 nm. The third method (C) depends on the reaction of the drug with acetylacetone and formaldehyde to form a coloured condensation product measured at 356 nm and also has a strong fluorescence at 475 nm (lambda(ex) 410 nm). This method is extended to determine lisinopril in binary mixtures with hydrochlorothiazide. The last method (D) depends on measuring the first and second derivative spectra of lisinopril. Moreover, the derivative method is used as stability-indicating method where lisinopril can be determined in presence of its degradation products. The proposed methods proved to be suitable for a rapid quality control of commercial dosage forms. The results obtained were precise and accurate.
El-Yazbi
F A
FA
Faculty of Pharmacy, Alexandria University, El-Mesallah, Egypt.
Abdine
H H
HH
Shaalan
R A
RA
D000959:Antihypertensive Agents / Q000032:analysis*; D002138:Calibration; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D017706:Lisinopril / Q000032:analysis*; D012015:Reference Standards; D013050:Spectrometry, Fluorescence / Q000379:methods*; D013053:Spectrophotometry / Q000379:methods*; D013607:Tablets / Q000737:chemistry
D000959:Antihypertensive Agents; D013607:Tablets; D017706:Lisinopril